Introduction Česky
 
Login |
 
registration
   
have you forgotten your password?
 
send
 

Internal Medicine

Fibrates in 2018: story goes on

Fibrates in 2018: story goes on

At present, pharmacological intervention for dyslipidemia (DLP) is primarily aimed at the effect of LDL-C statins. In monotherapy then possibly in combination with ezetimibe (or...

Authors: Richard Češka, Michal Vrablík, Tomáš Štulc
Issue: 3/2018

Read article

Lysosomal storage disorders as the cause of dyslipoproteinemia

Lysosomal storage disorders as the cause of dyslipoproteinemia

Lysosomal storage disorders (LSDs) belong to group of rare, inborn, inherited diseases. They are caused by insufficient activity of certain lysosomal enzymes, by error of a...

Authors: Anna Hlavatá, Katarína Juríčková
Issue: 3/2018

Read article

Detection of aortic calcifications within the assessment of lateral densitometric scans

Detection of aortic calcifications within the assessment of lateral densitometric scans

Cardiovascular morbidity and mortality still remain one of the main actual problems of modern medicine. Latterly, raising amounts of data are published on evaluation of...

Authors: Daniel Čierny, Kristína Brázdilová, Zdenko Killinger, Juraj Payer
Issue: 2/2018

Read article

Secondary and adverse effects of antihypertensive drugs

Secondary and adverse effects of antihypertensive drugs

It includes a brief overview of secondary and unwanted effects of basic antihypertensive drugs which may influence patients toward discontinuation of medication with the ensuing...

Authors: Jiří Vítovec, Jindřich Špinar
Issue: 1/2018

Read article

Arterial hypertension – a risk factor for sudden vascular stroke

Arterial hypertension – a risk factor for sudden vascular stroke

Strokes are among the most common causes of morbidity and mortality, and in individuals who suffered stroke, subsequent long-term neurological deficit in a larger or smaller...

Authors: Ľudovít Gašpar, Andrea Komorníková, Veronika Vestenická
Issue: 1/2018

Read article

Peripheral arterial disease of lower extremity and global cardiovascular risk

Peripheral arterial disease of lower extremity and global cardiovascular risk

Peripheral arterial disease (PAD) of lower extremity is predominantly a manifestation of atherothrombotic process. Effective cardiovascular risk treatment is underestimated in...

Authors: Denisa Čelovská, Viera Štvrtinová
Issue: 1/2018

Read article

Perspectives on central systolic pressure in clinical practice

Perspectives on central systolic pressure in clinical practice

The basic characteristic of blood circulation in humans is given by the cyclical work of the heart, which ejects the blood pulse volume into the arteries. The workload of left...

Authors: Mária Potočárová, Jozef Bulas, Viera Kupčová, Marta Filková, Ján Murín
Issue: 1/2018

Read article

Secondary dyslipidemia

Secondary dyslipidemia

Secondary dyslipidemia (DLP) arises as a result of other diseases or various exogenous influences. However, genetic predisposition, as it is known in the case of primary DLP...

Authors: Martin Šatný, Michal Vrablík
Issue: 3/2017

Read article

Intensive treatment of dyslipidemia in regional outpatient cardiology office

Intensive treatment of dyslipidemia in regional outpatient cardiology office

We presented briefly initial experiences of outpatient cardiologist in the first ever MedPed center in the Orava region. Reduction of low-density lipoprotein cholesterol (LDL...

Issue: 3/2017

Read article

The role of functional food and nutraceuticals in therapy of hypercholesterolemia

The role of functional food and nutraceuticals in therapy of hypercholesterolemia

Dyslipidemia, arterial hypertension, smoking and type 2 diabetes mellitus are the most important risk factors for cardiovascular diseases (CVD). The first step in treatment of...

Issue: 3/2017

Read article

 

Subscription

Subscribe the Journal

The subscription grants you full access to all the articles.

further information

 

Issue No.: 3 / 2018

show contents

 

 

Most read